论文部分内容阅读
目的:探讨和研究芪参胶囊对冠心病患者血液流变学的影响。方法:选取74例冠心病患者的临床资料作为研究对象,按照随机分组的原则将其分为观察组和对照组各37例,其中对照组采用常规治疗措施进行治疗,观察组在此基础上加用芪参胶囊进行治疗,统计并对比两组患者治疗前后的血液流变学变化。结果:观察组治疗后的全血比粘度(高切、低切)、红细胞聚集指数、全血还原粘度(高切、低切)以及红细胞刚性指数较治疗前均明显下降,较对照组而言有明显差异(P<0.05)。结论:芪参胶囊治疗冠心病患者效果较好,能够有效改变患者的血液流变学情况,加强心肌供血,值得临床推广和应用。
Objective: To investigate and study the Qishen capsule on patients with coronary heart disease hemorheology. Methods: The clinical data of 74 patients with coronary heart disease were selected as the research object. According to the principle of random grouping, the patients were divided into observation group and control group, 37 cases in each group. The control group was treated by conventional treatment. On the basis of this, With Qishen capsule for treatment, statistics and comparison of two groups of patients before and after treatment of hemorheological changes. Results: The whole blood viscosity (high and low cut), erythrocyte aggregation index, whole blood reducing viscosity (high and low cut) and erythrocyte rigidity index of observation group after treatment were significantly lower than those before treatment, compared with the control group There was a significant difference (P <0.05). Conclusion: Qishen capsule is effective in treating patients with coronary heart disease, which can effectively change the patients’ hemorheology and strengthen the blood supply to the myocardium, which is worthy of clinical promotion and application.